These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30121971)

  • 21. Procollagen-lysine, 2-oxoglutarate 5-dioxygenases 1, 2, and 3 are potential prognostic indicators in patients with clear cell renal cell carcinoma.
    Xu WH; Xu Y; Wang J; Tian X; Wu J; Wan FN; Wang HK; Qu YY; Zhang HL; Ye DW
    Aging (Albany NY); 2019 Aug; 11(16):6503-6521. PubMed ID: 31446433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of Nuclear BAP1 Expression Is Associated with High WHO/ISUP Grade in Clear Cell Renal Cell Carcinoma.
    Wi YC; Moon A; Jung MJ; Kim Y; Bang SS; Jang K; Paik SS; Shin SJ
    J Pathol Transl Med; 2018 Nov; 52(6):378-385. PubMed ID: 30269473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histopathological Prognostic Factors in Clear Cell Renal Cell Carcinoma.
    Andreiana BC; Stepan AE; Mărgăritescu C; Al Khatib AM; Florescu MM; Ciurea RN; Simionescu CE
    Curr Health Sci J; 2018; 44(3):201-205. PubMed ID: 30647938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of clinicopathological parameters with FoxM1 expression in renal cell carcinoma.
    Kocarslan S; Guldur ME; Ekinci T; Ciftci H; Ozardali HI
    J Cancer Res Ther; 2014; 10(4):1076-81. PubMed ID: 25579557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma.
    Liu Z; Liu Y; Xu L; An H; Chang Y; Yang Y; Zhang W; Xu J
    Cancer Sci; 2015 Sep; 106(9):1224-31. PubMed ID: 26179886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of amyloid A immunoexpression in the prognosis of renal cell carcinoma.
    Oz Atalay F; Aytac Vuruskan B; Vuruskan H
    APMIS; 2016 Apr; 124(4):257-62. PubMed ID: 26750935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
    Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
    Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive intratumoral chemokine (C-C motif) receptor 8 expression predicts high recurrence risk of post-operation clear-cell renal cell carcinoma patients.
    Fu Q; Chang Y; Zhou L; An H; Zhu Y; Xu L; Zhang W; Xu J
    Oncotarget; 2016 Feb; 7(7):8413-21. PubMed ID: 26716905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
    Brookman-May SD; May M; Wolff I; Zigeuner R; Hutterer GC; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Feciche B; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Zastrow S; Wirth M; Sountoulides P; Shariat S; Waidelich R; Stief C; Gunia S; ;
    Eur Urol; 2015 May; 67(5):943-51. PubMed ID: 25684695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
    Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intratumoral lymphatics and lymphatic invasion are associated with tumor aggressiveness and poor prognosis in renal cell carcinoma.
    Horiguchi A; Ito K; Sumitomo M; Kimura F; Asano T; Hayakawa M
    Urology; 2008 May; 71(5):928-32. PubMed ID: 18291512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orai1 Expression Is Closely Related with Favorable Prognostic Factors in Clear Cell Renal Cell Carcinoma.
    Lkhagvadorj S; Kim JH; Oh SS; Lee MR; Jung JH; Chung HC; Cha SK; Eom M
    J Korean Med Sci; 2016 Jun; 31(6):879-85. PubMed ID: 27247496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth pattern, an important pathologic prognostic parameter for clear cell renal cell carcinoma.
    Fukatsu A; Tsuzuki T; Sassa N; Nishikimi T; Kimura T; Majima T; Yoshino Y; Hattori R; Gotoh M
    Am J Clin Pathol; 2013 Oct; 140(4):500-5. PubMed ID: 24045546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DYSF expression in clear cell renal cell carcinoma: A retrospective study of 2 independent cohorts.
    Ha M; Jeong H; Roh JS; Lee B; Han ME; Oh SO; Sohn DH; Kim YH
    Urol Oncol; 2019 Oct; 37(10):735-741. PubMed ID: 31377166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray.
    Zerati M; Leite KR; Pontes-Junior J; Segre CC; Reis ST; Srougi M; Dall'Oglio MF
    Int Braz J Urol; 2013; 39(4):484-92. PubMed ID: 24054396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic role of myoferlin expression in patients with clear cell renal cell carcinoma.
    Song DH; Ko GH; Lee JH; Lee JS; Yang JW; Kim MH; An HJ; Kang MH; Jeon KN; Kim DC
    Oncotarget; 2017 Oct; 8(51):89033-89039. PubMed ID: 29179496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.